Characterization of an unknown impurity in doxofylline using LC–MS and NMR
- 1 June 2017
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 140, 31-37
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Development of Impurity Profiling Methods Using Modern Analytical TechniquesCritical Reviews in Analytical Chemistry, 2016
- Doxofylline, a novofylline inhibits lung inflammation induced by lipopolysacharide in the mousePulmonary Pharmacology & Therapeutics, 2014
- Development and validation of a stability indicating assay of doxofylline by RP-HPLC: ESI-MS/MS, 1H and 13C NMR spectroscopic characterization of degradation products and process related impuritiesJournal of Pharmaceutical and Biomedical Analysis, 2013
- Gas Phase Chemistry of Li+with Amides: the Observation of LiOH Loss in Mass SpectrometryJournal of the American Society for Mass Spectrometry, 2012
- Doxofylline: A “Novofylline”Pulmonary Pharmacology & Therapeutics, 2010
- Study of fragmentation pathways of lithiated α , β ‐unsaturated thioesters by electrospray ionization mass spectrometryRapid Communications in Mass Spectrometry, 2010
- Complete assignments of the 1H, 13C and 15N NMR spectra of caffeineSpectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 1995
- Preparation and NMR Study of 7,7′-(α,ω-Alkanediyl)bis[theophylline], 1,1′-(α,ω-Alkanediyl)bis[theobromine], and 1,1′-(α,ω-Alkanediyl)bis[3-methyluracil]Bulletin of the Chemical Society of Japan, 1994
- Doxofylline exerts a prophylactic effect against bronchoconstriction and pleurisy induced by PAFEuropean Journal of Pharmacology, 1989
- Über Purinderivate. 1. Mitteilung: Über Bis-Theophylline und ein symmetrisches 3,4-Dithia-1,6-diazacyclononanArchiv der Pharmazie, 1960